JOYCE O'SHAUGHNESSY, MD
Medical Oncology Physician · DALLAS, TX
Individual Active NPI 1790727709
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 858 | 153,554 | $12,878,768 | $3,557,518 | $2,836,128 |
| 2023 | 864 | 174,071 | $14,635,996 | $4,303,797 | $3,429,629 |
| 2022 | 881 | 117,912 | $9,191,903 | $2,821,134 | $2,258,355 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 20,400 | $56 | $45 |
| J1453 | Injection, fosaprepitant, 1 mg | 18,600 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 9,814 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 8,640 | $50 | $39 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 8,500 | $0 | $0 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 7,536 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 7,040 | $31 | $25 |
| J9025 | Injection, azacitidine, 1 mg | 5,500 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 3,300 | $26 | $20 |
| J1930 | Injection, lanreotide, 1 mg | 3,240 | $48 | $39 |
| J1756 | Injection, iron sucrose, 1 mg | 3,100 | $0 | $0 |
| J9073 | Injection, cyclophosphamide (ingenus), 5 mg | 2,718 | $1 | $1 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | K3366 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Texas
- NPI 1962595090
- NPI 1407898505
- NPI 1821257072
- NPI 1225328743
- NPI 1528591047
- NPI 1326368895
- NPI 1154530830
- NPI 1235171281
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.